Great volume today. This should help DYNT promote their product more efficiently. This quater should not be as great as anticipated but because of the FDA sales should improve in the long run. Go DYNT. Also go Z, Venator Group
This is more significant than one would think...This will allow the aggressive marketing campaign that the company had counted on when they were projecting great things for the Synergie line back in 1998 to begin. This should propel DYNT nicely over the short & long term.